Probiotics in gynaecology

• Autorzy: Uzar I.

Warianty tytułu

PL

Zastosowanie probiotyków w ginekologii

• Języki publikacji: EN

Abstrakty

EN

Probiotics are the bacterial strains living and reproducing in the gastrointestinal tract. They favorably influence human organism by maintaing the balance of intestinal microflora and vaginal biocenosis. Recently, the interest in probiotics bacteria has increased. They are used not only in prophylaxis, but also in treatment, especially in infectious diseases of gastrointestinal and genitourinary tracts.

PL

Probiotyki to szczepy bakterii, które mają zdolność przeżycia i namnażania się w przewodzie pokarmowym oraz działają korzystnie na organizm człowieka poprzez wpływ na równowagę mikroflory jelitowej i biocenozy pochwy. W ostatnich latach nastąpił wzrost zainteresowania bakteriami probiotycznymi, które oprócz wykorzystania w profilaktyce znajdują zastosowanie w lecznictwie, zwłaszcza w chorobach infekcyjnych przewodu pokarmowego i zakażeniach układu moczowo-płciowego u kobiet.

Słowa kluczowe

EN

probiotic; gynaecology; application; Lactobacillus; bacterial vaginosis

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2011
• Tom: 57
• Numer: 2
• Opis fizyczny: p.66-71,ref.

Twórcy

autor

Uzar I.

• Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University, Zolnierska 48, 71-210 Szczecin, Poland

Bibliografia

• 1. Wysocka M. Probiotics – new, hopefull uses in therapy. Nowa Pediatria 2001; 3:19-24.
• 2. Kędzia A. Probiotics activity in the human body. Part I. Significance of gastrointestinal tract natura flora. Postępy Fitoterapii 2008; 4:247-251.
• 3. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66:356-64.
• 4. Libudzisz Z, Walczak P, Bardowski J. The intestinal ecosystems and probiotic. Bacteria of milk fermentation – metabolizm, genetics, significance. ITFM 2003:76-84.
• 5. Malm A, Łoś R. Is the rational probiotictherapy the regulation on health for people in XXI century ? Aptekarz Polski on line 2009; 37(15), dostępne 18.04.2011.
• 6. Kędzia A. Probiotics activity in the human body. Part II. Application of probiotics in treatment and prevention of diseases. Postępy Fitoterapii 2009; 1:50-57.
• 7. Santon C et al. Market potential for probiotics. Am J Clin Nutr 2001; 73: 476-483.
• 8. Favier CF, de Vos WM, Akkermans ADL. Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe 2003; 9:219-29.
• 9. Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe 2005; 11: 247-51.
• 10. Osset J et al. Assesment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect 2001; 183(3):485-491.
• 11. Vanderhoof J et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999; 135:564-568.
• 12. Agerholm-Larsen L, Bell ML, Grunwald GK et al. The effect of probiotic milk product on plasma cholesterol: meta-analysis of short-term intervencion studies. Eur J Clin Nutr 2000; 54: 856-60.
• 13. Kochan P. Selected female genitourinary tract infections and their treatment according to CDC. WHO/ FAO criteria for probiotics and their use in gynecology basing on current research. Gin Prakt 2005; 87(6):11-18.
• 14. Reid G, Bruce A W. Urogenital infections in women: can probiotics help? Postgrad Med J 2003; 79:428- 32.
• 15. Spaczyński M, Drews K, Kotarski J, Kędzia W, Niemiec T. Recommendations of PTG for application of Lacibios Femina in obsterics and gynecology. Gin Prakt 2006; 3:34-35.
• 16. Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. Med Gen Med 2004; 6(1):49.
• 17. Henemann C, van Hylckama Vlieg JE, Janssen DB, Busscher HJ, van der Mei HC, Reid G. Purification and characterization of a surface-binding protein from Lactobacillus fermentum RC-14 inhibiting Enterococcus faecalis 1131 adhesion. FEMS Microbiol Lett 2000; 190:177-180.
• 18. Reid G, Charbonneau D, Erb J at al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC- 14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 helthy women. FEMS Immunol Med. Microbiol 2003; 35(2):131-4.
• 19. Tomaszewski J. Probiotcs to prevent infections. Postępy w Medycynie 2008; 10:173.
• 20. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 2006; 24:28-32.
• 21. Reid G, Buerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbial 2001; 32: 37-41.
• 22. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. Am J Obstet Gynecol 2003; 4:1202-1208.
• 23. Hilton E, Isenberg H D, Alperstein P, France K, Borenstein M T. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116(5):353-7.
• 24. Burton JP, Reid G. Evaluation of the bacterial vaginal flora of twenty postmenopausal women by direct (Nugent Score) and molecular techniques. J Infect Dis 2002; 186: 1777-1780.
• 25. Clarke JG, Peipert JF, Hillier SL et al. Microflora changes with the use of a vaginal microbicide. SexTransm Dis 2002; 29:288-93.